 Connection
Andres Henao Martinez to Fluconazole
This is a "connection" page, showing publications Andres Henao Martinez has written about Fluconazole.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
1.214 |
|
|
|
-
Edwards B, Ripperton R, Tilley A, Chastain DB, Thompson GR, Henao-Martínez AF. Insights into current coccidioidomycosis therapeutic pathways. Antimicrob Agents Chemother. 2025 12 10; 69(12):e0146525.
Score: 0.925
-
Henao-Martínez AF, Chastain DB, Thompson GR. Treatment pathways, switches, and inappropriate treatment during invasive pulmonary aspergillosis: real-world experiences from a global research network study. Antimicrob Agents Chemother. 2023 10 18; 67(10):e0072123.
Score: 0.199
-
Alanazi AH, Chastain DB, Rudraraju M, Parvathagiri V, Shan S, Lin X, Henao-Martínez AF, Franco-Paredes C, Narayanan SP, Somanath PR. A multi-arm, parallel, preclinical study investigating the potential benefits of acetazolamide, candesartan, and triciribine in combination with fluconazole for the treatment of cryptococcal meningoencephalitis. Eur J Pharmacol. 2023 Dec 05; 960:176177.
Score: 0.050
-
Mann S, Tobolowsky F, Purohit S, Henao-Martínez A, Bajrovic V, Ramanan P, Wolfel E, Khazanie P, Barron M, Madinger N, Benamu E. Cryptococcal pericarditis in a heart transplant recipient. Transpl Infect Dis. 2020 Dec; 22(6):e13366.
Score: 0.040
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|